Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | PLOS ONE
![Monitoring methotrexate hepatotoxicity in psoriasis - Indian Journal of Dermatology, Venereology and Leprology Monitoring methotrexate hepatotoxicity in psoriasis - Indian Journal of Dermatology, Venereology and Leprology](https://ijdvl.com/content/126/2011/77/5/Images/ijdvl_2011_77_5_545_84014_b1.jpg)
Monitoring methotrexate hepatotoxicity in psoriasis - Indian Journal of Dermatology, Venereology and Leprology
![Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica](https://www.medicaljournals.se/acta/html-editor/html-img/4881/4881_3603.png)
Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting | HTML | Acta Dermato-Venereologica
![Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/f4be0320-62d9-4f15-a5ea-5b0226a27eaf/gr1.gif)
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis (COMPLETE-PsA): a double-blind, placebo-controlled, randomised, trial - The Lancet Rheumatology
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | PLOS ONE
Dermatological guidelines for monitoring methotrexate treatment reduce drug-survival compared to rheumatological guidelines | PLOS ONE
Methotrexate Monitoring in Dermatology— A Retrospective Cohort Study - JDDonline - Journal of Drugs in Dermatology
![Frontiers | Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices Frontiers | Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices](https://www.frontiersin.org/files/Articles/1015200/fonc-12-1015200-HTML/image_m/fonc-12-1015200-g001.jpg)
Frontiers | Therapeutic drug monitoring for cytotoxic anticancer drugs: Principles and evidence-based practices
![PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1e4f0a9a3a90ec9f13d64e26c9737cc6afd59a2f/3-TableI-1.png)
PDF] Methotrexate Use and Monitoring in Patients with Psoriasis: A Consensus Report Based on a Danish Expert Meeting. | Semantic Scholar
![Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center](https://jhoponline.com/images/jhop/2021/April/AssessHigh-Dose_table1.jpg)